We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
-4.05%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$2.11B
AUM Growth
-$170M
Cap. Flow
-$54.7M
Cap. Flow %
-2.59%
Top 10 Hldgs %
25.5%
Holding
2,409
New
42
Increased
215
Reduced
756
Closed
94

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.75M
2
TSLA icon
Tesla
TSLA
+$1.84M
3
CSGP icon
CoStar Group
CSGP
+$1.61M
4
PCG icon
PG&E
PCG
+$1.12M
5
EQT icon
EQT Corp
EQT
+$955K

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Healthcare 13.97%
3 Financials 12.12%
4 Consumer Discretionary 10.21%
5 Industrials 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNAM
1476
DELISTED
Avidity Biosciences
RNAM
$48.5K ﹤0.01%
2,972
OBK icon
1477
Origin Bancorp
OBK
$1.67B
$48.5K ﹤0.01%
1,260
HBNC icon
1478
Horizon Bancorp
HBNC
$1.05B
$48.4K ﹤0.01%
2,696
OM icon
1479
Outset Medical
OM
$79.9M
$48.3K ﹤0.01%
202
PENG
1480
Penguin Solutions Inc
PENG
$3.12B
$48.3K ﹤0.01%
3,045
ADPT icon
1481
Adaptive Biotechnologies
ADPT
$3.89B
$48.1K ﹤0.01%
6,762
PEBO icon
1482
Peoples Bancorp
PEBO
$1.48B
$48.1K ﹤0.01%
1,664
ASTE icon
1483
Astec Industries
ASTE
$994M
$48.1K ﹤0.01%
1,541
BALY icon
1484
Bally's
BALY
$671M
$48.1K ﹤0.01%
2,432
ALLO icon
1485
Allogene Therapeutics
ALLO
$683M
$47.9K ﹤0.01%
4,433
ANGO icon
1486
AngioDynamics
ANGO
$647M
$47.9K ﹤0.01%
2,339
PDFS icon
1487
PDF Solutions
PDFS
$2.19B
$47.8K ﹤0.01%
1,947
TTEC icon
1488
TTEC Holdings
TTEC
$77.4M
$47.6K ﹤0.01%
1,075
SAFE
1489
DELISTED
Safehold Inc.
SAFE
$47.5K ﹤0.01%
1,797
-145
-7% -$5.65K
TGTX icon
1490
TG Therapeutics
TGTX
$7.58B
$47.5K ﹤0.01%
8,029
+1,790
+29% +$11.7K
MATW icon
1491
Matthews International
MATW
$725M
$47.4K ﹤0.01%
2,114
JBSS icon
1492
John B. Sanfilippo & Son
JBSS
$989M
$47.3K ﹤0.01%
624
DLX icon
1493
Deluxe
DLX
$1.09B
$47.2K ﹤0.01%
2,837
DCH
1494
Dauch Corp
DCH
$1.61B
$47.1K ﹤0.01%
6,900
+1,061
+18% +$9.55K
ARQT icon
1495
Arcutis Biotherapeutics
ARQT
$3.3B
$47.1K ﹤0.01%
2,466
+337
+16% +$7.64K
ONL
1496
Orion Office REIT
ONL
$161M
$47.1K ﹤0.01%
5,382
-749
-12% -$7.68K
GBX icon
1497
The Greenbrier Companies
GBX
$1.41B
$47.1K ﹤0.01%
1,939
XRN
1498
Chiron Real Estate Inc
XRN
$480M
$47.1K ﹤0.01%
1,105
-163
-13% -$8.99K
TA
1499
DELISTED
TravelCenters of America LLC
TA
$46.9K ﹤0.01%
870
ATRI
1500
DELISTED
Atrion Corp
ATRI
$46.9K ﹤0.01%
83

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 Portfolio in Review

As of Q3 2022, Metropolitan Life Insurance Company (MetLife) held 2,409 positions worth $2.11B, down 7.5% from $2.28B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 filing shows 42 new, 215 increased, 756 reduced and 94 closed positions. Its largest new stake was CoStar Group: 23,153 shares worth $1.61M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $11.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2022 buy was CoStar Group: 23,153 shares worth $1.61M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $3.75M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $11.4M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Healthcare Realty Trust Incorporated in Q3 2022, selling an estimated $433K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $2.11B portfolio in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 42 new positions and closed 94 in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 7.5% quarter-over-quarter to $2.11B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.